2Stanhope, KL & Havel, PJ (2008) Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose or high fructose corn syrup. Am J Clin Nutr 88, 1733S–1737S.
3Fried, SK & Rao, SP (2003) Sugars, hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 78, 873S–880S.
4Kawasaki, T, Kashiwabara, A, Sakai, T, et al. (2005) Long term sucrose-drinking causes increased body weight and glucose intolerance in normal male rats. Br J Nutr 93, 613–618.
5Barnard, RJ, Faria, DJ, Menges, JE, et al. (1993) Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Atherosclerosis 100, 229–236.
6Mela, DJ (1997) Impact of macronutrient-substituted foods on food choice and dietary intake. Ann N Y Acad Sci 819, 96–107.
7Probert, HM, Apajalahti, JHA, Rautonen, N, et al. (2004) Polydextrose, lactitol and fructo-oligosaccharide fermentation by colonic bacteria in a three stage continuous culture system. Appl Environ Microbiol 70, 4505–4511.
8Ghoddusi, HB, Grandison, MA, Grandison, AS, et al. (2007) In vitro study on gas generation and prebiotic effects of some carbohydrates and their mixtures. Anaerobe 13, 193–199.
9Arrigoni, E, Brouns, F & Amadò, R (2005) Human gut microbiota does not ferment erythritol. Br J Nutr 94, 643–646.
10Tsukamura, M, Goto, H, Arisawa, T, et al. (1998) Dietary maltitol decreases the incidence of 1,2-dimethylhydrazine induced cecum and proximal colon tumors in rats. J Nutr 128, 536–540.
11DiBaise, JK, Zhang, H, Crowell, MD, et al. (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83, 460–469.
12Steer, T, Carpenter, H, Tuohy, KM, et al. (2000) Perspectives on the role of the human gut microbiota in health and methods of study. Nutr Res Rev 13, 229–254.
13Egert, M, de Graaf, AA, Smidt, H, et al. (2005) Beyond diversity: functional microbiomics of the human colon. Trends Microbiol 14, 86–91.
14Blaut, M & Clavel, T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137, 751–755.
15Cummings, JH, Pomare, EW, Branch, WJ, et al. (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227.
16Cook, SI & Sellin, JH (1998) Review Article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 12, 499–507.
17Hijova, E & Chmelarova, A (2007) Short chain fatty acids and colonic health. Bratisl Lek Listy 108, 354–358.
18Macfarlane, GT & Gibson, GR (1997) Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine. In Gastrointestinal Microbiology, pp. 269–318 [Mackie, RI and White, BH, editors]. London: Chapman & Hall.
19Roediger, WEW (1989) The utilisation of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83, 424–429.
20Demigné, C, Morand, C, Levrat, MA, et al. (1995) Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 74, 209–219.
21Wolever, T, Spadafora, P & Eshuis, H (1991) Interaction between colonic acetate and propionate in humans. Am J Clin Nutr 53, 681–687.
22Emenaker, NJ, Calaf, GM, Cox, D, et al. (2001) Short chain fatty acids inhibit invasive human colon cancer by modulating Upa, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and pcna protein expression in an in vitro cell culture model. J Nutr 131, 3041–3046.
23Hong, FU, Ying Qiang, SHO & Shan Jin, MO (2002) Effect of short chain fatty acids on the human colonic adenocarcinoma cell line Caco-2. Chin J Dig Dis 5, 115–117.
24Mortensen, PB & Clausen, MR (1996) Short chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 31, 132–148.
25Galvez, J, Rodriquez-Cabezas, ME & Zarzuelo, A (2005) Effects of dietary fibre on inflammatory bowel disease. Mol Nutr Food Res 49, 601–608.
26Gibson, GR, Probert, HM, Van Loo, JAE, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 257–259.
27Kolida, S & Gibson, GR (2007) Prebiotic capacity of inulin-type fructans. J Nutr 137, S2503–S2506.
28Kolida, S, Tuohy, KM & Gibson, GR (2002) Prebiotic effects of inulin and oligofructose. Br J Nutr 87, S193–S197.
29Gibson, GR (1999) Dietary modulation of the human gut microflora using prebiotics oligofructose and inulin. J Nutr 129, 1438S–1441S.
30Cummings, JH, Macfarlane, GT & Englyst, HN (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 73, S415–S420.
31Langkilde, AM, Anderson, H, Schweizer, TF, et al. (1994) Digestion and absorption of sorbitol, maltitol and isomalt from the small bowel. A study in ileostomy subjects. Eur J Clin Nutr 48, 768–775.
32Figdor, SK & Bianchine, JR (1983) Caloric utilization of [14C]polydextrose in man. J Agric Food Chem 31, 389–393.
33Silvester, KR, Englyst, HN & Cummings, JH (1995) Ileal recovery of starch from whole diets containing resistant starch measured in vitro and fermentation of ileal effluent. Am J Clin Nutr 62, 403–411.
34Storey, DM, Koutsou, GA, Lee, A, et al. (1998) Tolerance and breath hydrogen excretion following maltitol incorporated at two levels into milk chocolate consumed by healthy young adults with and without fasting. J Nutr 128, 587–592.
35Flood, MT, Auerbach, MH & Craig, SAS (2004) A review of the clinical tolerance studies of polydextrose in food. Food Chem Toxicol 42, 1531–1542.
36Langendijk, PS, Schut, F, Jansen, GJ, et al. (1995) Quantitative fluorescent in situ hybridisation of Bifidobacterium spp. with genus-specific rRNA-targeted probes and its application in faecal samples. Appl Environ Microbiol 61, 3069–3075.
37Manz, W, Amann, R, Ludwig, W, et al. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga–flavobacter–bacteroides in the natural environment. Microbiology 142, 1097–1106.
38Franks, AH, Harmsen, HJ, Raangs, GC, et al. (1998) Variations of bacterial populations in human faeces measured by fluorescent in situ hybridisation with group specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336–3345.
39Harmsen, HJM, Elfferich, P, Schut, F, et al. (1999) A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11, 3–12.
40Harmsen, HJM, Wilderboer-Veloo, ACM, Grijpstra, J, et al. (2000) Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66, 4523–4527.
41Suau, A, Rochet, V, Sghir, A, et al. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human faecal flora. Syst Appl Microbiol 24, 139–145.
42Harmsen, HJM, Raangs, GC, He, T, et al. (2002) Extensive set of 16S rRNA-based probes for detection of bacteria from human faeces. Appl Environ Microbiol 68, 2982–2990.
43Zhao, G, Nyman, M & Jönsson, JA (2006) Rapid determination of short chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct injection gas chromatography. Biomed Chrom 20, 674–682.
44Sokol, H, Pigneur, B, Watterlot, L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of crohns disease patients. Proc Natl Acad Sci U S A 105, 16731–16736.
45Silvi, S, Rumney, A, Cresci, A, et al. (1999) Resistant starch modifies gut microflora and microbial metabolism in human flora associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 86, 521–530.
46Lesmes, U, Beards, E, Gibson, GR, et al. (2008) Effects of resistant starch type III polymorphs on human colon microbiota and short chain fatty acids in human gut models. J Agric Food Chem 56, 5415–5421.
47Oku, T, Akiba, M, Lee, MH, et al. (1991) Metabolic fate of ingested [14C]-maltitol in man. J Nutr Sci Vitaminol 37, 529–544.
48Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria and gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia 50, 2374–2383.
49Lee, HY, Park, JH, Seok, HJ, et al. (2006) Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochem Biophys Acta 1761, 736–744.
50Lucke, K, Miehlke, S, Jacobs, E, et al. (2006) Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 55, 617–624.
51Ley, RE, Bäckhed, F, Turnbaugh, PJ, et al. (2007) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 11070–11075.
52Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023.
53Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
54Duncan, SH, Holtrop, G, Lobley, GE, et al. (2004) Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91, 915–923.
55Cummings, JH & Macfarlane, GT (2002) Gastrointestinal effects of prebiotics. Br J Nutr 87, 5145–5515.